Abstract
Type 1 diabetes (T1D) is a chronic autoimmune disorder that results from destruction of the insulin-producing pancreatic β-cells. The disease mainly affects juveniles. Changes in the composition of the gut microbiota (dysbiosis) and changes in the properties of the gut barrier have been documented in T1D subjects. Because these factors affect immune system functions, they are likely to play a role in disease pathogenesis. However, their exact role is currently not fully understood and is under intensive investigation. In this article we discuss recent advancements depicting the role of intestinal dysbiosis on immunity and autoimmunity in T1D. We also discuss therapies aimed at maintaining a healthy gut barrier as prevention strategies for T1D.
| Translated title of the contribution | Current understanding of the role of gut dysbiosis in type 1 diabetes |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 632-644 |
| Number of pages | 13 |
| Journal | Journal of Diabetes |
| Volume | 11 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2019 |
Keywords
- autoimmunity
- dysbiosis
- gut barrier
- microbiome
- type 1 diabetes
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism